{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:34:53Z","timestamp":1793216093359,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cjco.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:39:57Z","timestamp":1749757197000},"page":"1271-1281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prescription Drug Coverage of Guideline-Directed Medical Therapy for People Living with Heart Failure with Reduced Ejection Fraction in Canada"],"prefix":"10.1016","volume":"7","author":[{"given":"Simone S.","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Kosar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"Costigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anique","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Gewarges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Groulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McKelvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2025.05.018_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjco.2025.05.018_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/CIRCHEARTFAILURE.112.968735","article-title":"The three-phase terrain of heart failure readmissions","volume":"5","author":"Desai","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.05.018_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCOUTCOMES.110.957571","article-title":"Population impact of heart failure and the most common forms of cancer","volume":"3","author":"Stewart","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjco.2025.05.018_bib5","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.9778\/cmajo.20150130","article-title":"The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis","volume":"4","author":"Tran","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cjco.2025.05.018_bib6","first-page":"531","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.05.018_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jchf.2022.10.013","article-title":"Patient eligibility for established and novel guideline-directed medical therapies after acute heart failure hospitalization","volume":"11","author":"Moghaddam","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjco.2025.05.018_bib8","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.jacc.2022.03.351","article-title":"Underutilization of guideline-directed medical therapy in heart failure: Can digital health technologies PROMPT change?","volume":"79","author":"Van Spall","year":"2022","journal-title":"JACC"},{"key":"10.1016\/j.cjco.2025.05.018_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ejhf.3133","article-title":"Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?","volume":"26","author":"Greene","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2025.05.018_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14211","article-title":"Cost-related medication nonadherence and desire for medication cost information among adults aged 65 years and older in the US in 2022","volume":"6","author":"Dusetzina","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2025.05.018_bib11","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventative medications after myocardial infarction","volume":"365","author":"Choudhury","year":"2011","journal-title":"NEJM"},{"key":"10.1016\/j.cjco.2025.05.018_bib34","first-page":"1469","article-title":"Access to heart failure services in Canada: findings of the Heart and Stroke National Heart Failure Resources and Services Inventory","volume":"39","author":"Moghaddam","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.05.018_bib36","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"83","author":"Maddox","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.cjco.2025.05.018_bib37","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"McDonagh","year":"2023","journal-title":"EHJ"},{"key":"10.1016\/j.cjco.2025.05.018_bib38","first-page":"321","article-title":"Optimal usage of sacubitril\/valsartan for the treatment of heart failure: the importance of optimizing heart failure care in Canada","volume":"2","author":"Huitema","year":"2020","journal-title":"Can J Cardiol Open"},{"key":"10.1016\/j.cjco.2025.05.018_bib39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cvr\/cvad026","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"119","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2025.05.018_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"NEJM"},{"key":"10.1016\/j.cjco.2025.05.018_bib41","first-page":"632","article-title":"A novel approach to medical management of heart failure with reduced ejection fraction","volume":"37","author":"Miller","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.05.018_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2025.05.018_bib43","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/2047487319835042","article-title":"Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction","volume":"26","author":"Veenis","year":"2019","journal-title":"Eur J Prev Cardiol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25004044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25004044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:19:21Z","timestamp":1793215161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X25004044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2589790X25004044"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2025.05.018","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription Drug Coverage of Guideline-Directed Medical Therapy for People Living with Heart Failure with Reduced Ejection Fraction in Canada","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}